DruSO-CU

This international project aims to calculate the drug survival of omalizumab in a large multicenter daily practice cohort of patients with CU treated in UCARE centers, and identify determinants of drug survival in this overall international population differentiated by reason of discontinuation.

Contact: H.Rockmann@umcutrecht.nl

In this episode, our host is joined by UK-based dermatologist Dr Clive Grattan to address some of the most important unanswered questions in the field of chronic spontaneous urticaria.

LINK: www.medthority.com/csu-learning-zone/podcast-series/

Read more

Join Drs Martin Metz and Ana Maria Giménez-Arnau as they discuss the latest data on new treatments in development for chronic spontaneous urticaria.

The goal of this activity is to educate on the latest therapeutic developments for the management of patients with chronic spontaneous urticaria (CSU)

https://www.medscape.org/viewarticle/953107?src=acdmpart_ucare_953107

Martin Metz, MD; Ana Maria...

Read more

We are very pleased to announce that this year’s UCARE Conference will be held on December 9th-11th, 2021 in Hiroshima, Japan.

Read more

Contact us

GA²LEN coordinating Office
c/o DGAKI
Robert-Koch-Platz 7
10115 Berlin, Germany

UCARE office
Laura Schwenner

info(at)ga2len-ucare.com